Linked Life Data

19692680

Source:http://linkedlifedata.com/resource/pubmed/id/19692680

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2009-9-3
pubmed:databankReference
pubmed:abstractText
Previous, uncontrolled studies have suggested that first-line treatment with gefitinib would be efficacious in selected patients with non-small-cell lung cancer.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1533-4406
pubmed:author
pubmed:copyrightInfo
2009 Massachusetts Medical Society
pubmed:issnType
Electronic
pubmed:day
3
pubmed:volume
361
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
947-57
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:19692680-Adenocarcinoma, pubmed-meshheading:19692680-Adult, pubmed-meshheading:19692680-Aged, pubmed-meshheading:19692680-Aged, 80 and over, pubmed-meshheading:19692680-Antineoplastic Agents, pubmed-meshheading:19692680-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:19692680-Carboplatin, pubmed-meshheading:19692680-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:19692680-Disease-Free Survival, pubmed-meshheading:19692680-Female, pubmed-meshheading:19692680-Humans, pubmed-meshheading:19692680-Kaplan-Meier Estimate, pubmed-meshheading:19692680-Lung Neoplasms, pubmed-meshheading:19692680-Male, pubmed-meshheading:19692680-Middle Aged, pubmed-meshheading:19692680-Mutation, pubmed-meshheading:19692680-Paclitaxel, pubmed-meshheading:19692680-Proportional Hazards Models, pubmed-meshheading:19692680-Protein Kinase Inhibitors, pubmed-meshheading:19692680-Quinazolines, pubmed-meshheading:19692680-Receptor, Epidermal Growth Factor
pubmed:year
2009
pubmed:articleTitle
Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.
pubmed:affiliation
State Key Laboratory in Oncology in South China, Sir YK Pao Centre for Cancer, Department of Clinical Oncology, Chinese University of Hong Kong, Hong Kong. tony@clo.cuhk.edu.hk
pubmed:publicationType
Journal Article, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III